December 12, 2025
Sex-specific cardiac emulators enable rapid, accurate prediction of drug-induced QT prolongation, improving the safety and efficiency of in silico clinical trials while capturing critical differences
December 12, 2025
ELEM Biotech’s CEO, Christopher Morton, explained to El Periódico how the company develops digital replicas of human organs, including the heart. These digital twins allow simulation of
December 10, 2025
This study presents a proof-of-principle pipeline to build personalized digital cardiac twins by integrating cardiovascular MRI and electrocardiographic imaging, demonstrating how engineers,
December 10, 2025
At the Mobile World Congress (MWC), ELEM Biotech, in collaboration with the Barcelona Supercomputing Center (BSC), presented a “replicating heart” prototype. “This is not the future—it is
December 8, 2025
Insights from leading experts on excellence in scientific research and the technological foundations of virtual
December 1, 2025
Insights from leading experts on excellence in scientific research and the technological foundations of virtual
November 25, 2025
There is no excerpt because this is a protected
November 24, 2025
Insights from leading experts on regulation, ethics, and the responsible deployment of Virtual
November 17, 2025
Insights from leading experts on strategic leadership and real-world clinical adoption of Virtual
November 4, 2025
ELEM Biotech is taking part in the ESC Digital & AI, taking place 21–22 November in Berlin,
October 16, 2025
ELEM Biotech is participating in the Safety Pharmacology Society (SPS) Annual Meeting, taking place 13–15 October 2025 in Utrecht,
October 12, 2025
ELEM Biotech is participating in the Safety Pharmacology Society (SPS) Annual Meeting, taking place 13–15 October 2025 in Utrecht,
